Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Computational and Structural Biotechnology Journal|November 13, 2023
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging 'nonmutational epigenetic reprogramming' cancer hallmarkCandida Fasano, Martina Lepore Signorile, Elisabetta Di Nicola, et al.
Cells|October 27, 2023
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric CancerKatia De Marco, Martina Lepore Signorile, Elisabetta Di Nicola, et al.
Cells|November 24, 2023
SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA DamageMartina Lepore Signorile, Paola Sanese, Elisabetta Di Nicola, et al.
Nutrients|April 26, 2025
The Protective Effect of FOXO3 rs2802292 G-Allele on Food Intake in a Southern Italian Cohort Affected by MASLDRossella Donghia, Elisabetta Di Nicola, Rossella Tatoli, et al.
International Journal of Molecular Sciences|February 27, 2026
The Interplay of Genetics and Lifestyle in MASLD: Focus on LPIN1 rs13412852 and Sedentary BehaviourIsabella Franco, Rossella Donghia, Antonella Bianco, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2024
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistancePaola Sanese, Katia De Marco, Martina Lepore Signorile, et al.
Signal Transduction and Targeted Therapy|June 30, 2025
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axisMartina Lepore Signorile, Elisabetta Di Nicola, Giovanna Forte, et al.
Pageof 1